UNSPSC 51391741: Tobuterol

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17B9PXO2SW. European Medicines Agency schedules Tobuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11135MIG. Tobuterol generally arises in the molecular formula C28H31NO5.

UNSPSC 51391741 Tobuterol, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record is Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, soliciting naloxone and safe drug deactivation systems—products unrelated to tobuterol, a beta-2 agonist bronchodilator. The mismatch suggests a tagging error in the underlying opportunity record rather than genuine procurement activity under this code's nominal scope.

The Seminole County opportunity is the only recent state and local record available under this code. The county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. Bidders must provide unit pricing, comply with drug-free workplace and E-Verify requirements, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract spans two years with a one-year renewal option and includes a three-month probationary termination clause. This code shows little relevant recent activity for tobuterol or related respiratory therapeutics in state and local procurement.